Shaperon to Co-Develop Nuselin and Explore Technology Transfer at BioJapan 2026
Predicted impact: Low· Actual: −16.3% vs sector, volume 1.2× normal (5 trading days)
Co-development and technology transfer exploration is vague with no terms or value disclosed.